
Non-profit drug maker will provide insulin for no more than $30 a vial
CNN
Civica Rx, a nonprofit generic drug maker backed by hospitals, insurers and philanthropies, plans to manufacture and sell insulin for no more than $30 a vial. It is expected to be available as soon as early 2024, pending federal approval. Insulin has been a poster child for the soaring cost of prescription drugs.
Insulin, which more than 8 million Americans with diabetes depend on, has been a poster child for the soaring cost of prescription drugs.
Though insulin was discovered more than a century ago and costs little to make, the list price of the brand name products that Civica Rx is targeting is roughly $300 per vial, according to the Gary and Mary West Foundation, which co-founded Civica Rx. The cost has nearly tripled since 2010.

A little-known civil rights office in the Department of Education that helps resolve complaints from students across the country about discrimination and accommodating disabilities has been gutted by the Trump administration and is now facing a ballooning backlog, a workforce that’s in flux and an unclear mandate.












